Mesoblast's market cap is currently $2.07B. The company's EPS TTM is $-0.43; its P/E ratio is ―; Mesoblast is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
